JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 342
- +6+1.79%
20min DelayMarket Closed Sep 27 15:00 JST
23.11BMarket Cap-10850P/E (Static)
350High332Low2.59MVolume338Open336Pre Close877.86MTurnover93052wk High40.76%Turnover Ratio67.58MShares14252wk Low-31.519EPS TTM2.17BFloat Cap930Historical HighLossP/E (Static)6.35MShs Float142Historical Low-31.519EPS LYR5.36%Amplitude--Dividend TTM6.80P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
Founded2017-10-12
MarketTSE Growth
Fiscal Year Ends08-31
Address2-26-1 Muraoka-Higashi Kanagawa
Zip Code251-0012
Phone03-6661-9543
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --
- Yukari Nishikata
- Independent Director
- --
- Kousuke Ishii
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data